Hormone replacement therapy and risk for foot, distal forearm, proximal humerus, and pelvis fractures

Osteoporosis International

Volumn 14, Issue 6, 2003, Pages 469-475

  Keegan, Theresa H M ^a   Gopalakrishnan, Geetha ^a   Sidney, Stephen ^b   Quesenberry Jr , Charles P ^b   Kelsey, Jennifer L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

Distal forearm fractures; Foot fractures; Hormone replacement therapy; Pelvis fractures; Postmenopause; Proximal humerus fractures

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ETHNOLOGY; FEMALE; FOOT; FOREARM FRACTURE; GENDER; GROUPS BY AGE; HORMONE SUBSTITUTION; HUMAN; HUMERUS FRACTURE; MAJOR CLINICAL STUDY; MENOPAUSE; PELVIS FRACTURE; PRIORITY JOURNAL; QUESTIONNAIRE; RACE; RISK; STATISTICAL ANALYSIS;

AGED; CASE-CONTROL STUDIES; FEMALE; FOOT INJURIES; FOREARM INJURIES; FRACTURES, BONE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; PELVIC BONES; POSTMENOPAUSE; QUESTIONNAIRES; RISK FACTORS; SHOULDER FRACTURES; TIME FACTORS;

EID: 0042707570     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00198-003-1379-2     Document Type: Article

References (23)

1. Cauley JA, Salamone LM (2001) Postmenopausal endogenous and exogenous hormones, degree of obesity, thiazide diuretics, and risk of osteoporosis. In: Marcus R, Feldman D, Kelsey JL (eds) Osteoporosis, 2nd edn, Vol 1. Academic Press, San Diego, pp 741-769
2. Mosekilde L, Beck-Nielsen H, Sorensen OH, Nielsen SP, Charles P, Vestergaard P, Hermann AP, Gram J, Hansen TB, Abrahamsen B, Ebbesen EN, Stilgren L, Jensen LB, Brot C, Hansen B, Tofteng CL, Eiken P, Kolthoff N (2000) Hormone replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study. Maturitas 36:181-193
3. Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principle results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
4. Torgerson DJ, Bell-Syer SEM (2001) Hormone replacement therapy and prevention of nonvertebral fractures: a metaanalysis of randomized trials. JAMA 285:2891-2897
5. Hully S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W et al (2002) Noncardiovascular disease outcomes during 6.8 years of hormone therapy: the Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288:58-66
6. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR, Study of Osteoporotic Fractures Research Group (1995) Estrogen replacement therapy and fractures in older women. Ann Intern Med 122:9-16
7. Kelsey JL, Browner WS, Seeley DG, Nevitt MC, Cummings SR (1992) Risk factors for fractures of the distal forearm and proximal humerus. Am J Epidemiol 135:477-489
8. Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR (1980) Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 303:1195-1198
9. Williams AR, Weiss NS, Ure CL, Ballard J, Daling JR (1982) Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women. Obstet Gynecol 60:695-699
10. Melton LJ III, Crowton CS, O'Fallon WM (1999) Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporosis Int 9:29-37
11. Seeley, DG, Kelsey J, Jergas M, Nevitt MC (1996) Predictors of ankle and foot fractures in older women. J Bone Miner Res 11:1347-1355
12. Lindsay R, Cosman F (2001) Estrogens and osteoporosis. In: Marcus R, Feldman D, Kelsey JL (eds) Osteoporosis, 2nd edn, Vol 2. Academic Press, San Diego, pp 577-601
13. Riggs BL, Khosla S, Melton JL III (2001) The type I/type II model for involutional osteoporosis. In: Marcus R, Feldman D, Kelsey JL (eds) Osteoporosis, 2nd edn, Vol 2. Academic Press, San Diego, pp 49-58
14. WHO (1992) International Statistical Classification of Diseases and Health Related Problems, 10th revision, Vol 1. World Health Organization, Geneva
15. Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H (1983) Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 140:734-739
16. Gold EB, Bromberger J, Crawford S, Samuels S, Greendale GA, Harlow SD, Skurnick J (2001) Factors associated with age at natural menopause in a multi-ethnic sample of midlife women. Am J Epidemiol 153:865-874
17. Gallagher JC (1996) Estrogen: prevention and treatment of osteoporosis. In: Marcus R, Feldman D, Kelsey JL (eds) Osteoporosis. Academic Press, San Diego, pp 1191-1208
18. Quigley MET, Martin PL, Burnier AM, Brooks P (1987) Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol 156:1516-1523
19. Tremollieres FA, Pouilles JM, Ribot C (2001) Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women. Osteoporosis Int 2001:385-390
20. Hadji P, Hars O, Schuler M, Block K, Wuster C, Emons G, Schulz K (2000) Assessment by quantitative ultrasonometry of the effects of hormone replacement therapy on bone mass. Am J Obstet Gynecol 182:529-534
21. Weiss M, Ben Shlomo A, Hagag P, Rapoport M, Ish-Shalom S (2000) Effect of estrogen therapy on speed of sound at multiple skeletal sites. Maturitas 35:237-243
22. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P (1996) Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 143:971-978
23. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. N Engl J Med 332:767-773